Key result
Cardiogenetics sees tremendous 25-year growth in the Netherlands driven by founder mutations and family screening.
Why the study?
Cardiogenetics has experienced tremendous growth over the past 25 years, prompting a review of progress and newly arisen challenges in the field, particularly in the Netherlands.
This review highlights the 25-year evolution of cardiogenetics in the Netherlands, emphasizing the clinical utility of genetic screening for inherited cardiac diseases and the emerging challenge of interpreting variants of unknown significance.
Answers are grounded in this paper and cite their sources.
Supports broader cardiogenetic family screening; leaves open standardized VUS interpretation in clinical practice.
The cardiology and clinical genetics subspecialty of cardiogenetics has experienced a tremendous growth in the past 25 years. This review discusses examples of the progress that has been made as well as new challenges that have arisen within this field, with special focus on the Netherlands. A significant number of Dutch founder mutations, i.e. mutations shared by a number of individuals who have a common origin and all share a unique chromosomal background on which the mutation occurred, have been identified and have provided unique insights into genotype-phenotype correlations in inherited arrhythmia syndromes and inherited cardiomyopathies.Cardiological and genetic screening of family members of young victims of sudden cardiac death combined with genetic testing in the deceased individual have turned out to be rewarding. However, the interpretation of the results of genetic testing in this setting and in the setting of living patients with a (suspected) phenotype is now considered more challenging than previously anticipated, because the introduction of high-throughput sequencing technologies has resulted in the identification of a significant number of variants of unknown significance. Interpretation of genetic and clinical findings by experienced multidisciplinary teams are key to ensure a high quality of care to the patient and the family.
No takes yet. Share an insight, caveat, or question.
Wilde et al. (2020) conducted a review in Inherited cardiac diseases. Cardiogenetic screening and testing was evaluated. Cardiogenetics has experienced tremendous growth over the past 25 years in the Netherlands, driven by the identification of founder mutations and the implementation of multidisciplinary family screening.
Synapse has enriched 10 related papers. Consider them for comparative context: